Rheonix, Inc
About
Rheonix, Inc. is a molecular diagnostics company based in Ithaca, New York, founded in 2008 by Greg Galvin, Ph.D. The company specializes in developing automated, microfluidic-based solutions to enhance molecular testing accessibility across clinical, research, and applied testing markets. Rheonix aims to simplify traditional workflows with fully automated systems, improving standards of care through cost-effective testing solutions. The company offers the Encompass Workstation, a fully automated platform for multiplexed molecular testing, and the CARD Cartridge, a disposable microfluidic cartridge for various molecular assays. Its clinical assays include the FDA-authorized COVID-19 MDx Assay and the STI TriPlex Assay. In applied testing, Rheonix provides the Listeria PatternAlert™ Assay and the Beer SpoilerAlert™ Assay. The company has also collaborated with the FDA to develop an automated test for Cyclospora cayetanensis, enhancing food safety measures. Rheonix serves clinical laboratories, food safety and beverage industries, and research institutions, focusing on delivering rapid and reliable molecular analysis.